Invenra’s antibody gains US FDA designations for neuroblastoma treatment
Invenra received rare pediatric disease designation (RPDD) and orphan drug designation (ODD) from the FDA for INV724 to treat neuroblastoma.
Invenra received rare pediatric disease designation (RPDD) and orphan drug designation (ODD) from the FDA for INV724 to treat neuroblastoma.
What's Your Reaction?
